Holdings of Rosalind Advisors, Inc.
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 25 in 1 countries
- Top ten
- 78.4 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Delcath Systems Inc | 3,300,389 | 30.6M $ | |
| 2 | Xeris Biopharma Holdings Inc | 3,231,700 | 18.7M $ | |
| 3 | Savara Inc | 3,203,721 | 17.5M $ | |
| 4 | Vaxcyte Inc | 290,000 | 16.9M $ | |
| 5 | EyePoint Inc | 1,036,737 | 13.4M $ | |
| 6 | X4 PHARMACEUTICALS INC | 3,214,766 | 13.3M $ | |
| 7 | Vor BioPharma Inc | 700,000 | 12.5M $ | |
| 8 | Verastem Inc | 2,138,475 | 11.3M $ | |
| 9 | Celldex Therapeutics Inc | 330,000 | 10.5M $ | |
| 10 | BioCryst Pharmaceuticals Inc | 923,057 | 8.8M $ | |
| 11 | CG oncology Inc | 100,000 | 6.8M $ | |
| 12 | InspireMD, Inc. | 3,905,743 | 6.4M $ | |
| 13 | Atea Pharmaceuticals Inc | 1,171,855 | 6.3M $ | |
| 14 | Viridian Therapeutics Inc | 250,401 | 4.9M $ | |
| 15 | Myomo Inc | 3,847,272 | 2.6M $ | |
| 16 | TALPHERA INC | 3,353,916 | 2.5M $ | |
| 17 | Ovid therapeutics Inc | 1,107,994 | 2.5M $ | |
| 18 | OnKure Therapeutics Inc | 443,763 | 1.8M $ | |
| 19 | Lipocine Inc | 221,616 | 1.8M $ | |
| 20 | NEURAXIS INC | 286,138 | 1.7M $ | |
| 21 | AVALO THERAPEUTICS INC | 75,000 | 1.1M $ | |
| 22 | Annexon Inc | 200,000 | 1.1M $ | |
| 23 | Aquestive Therapeutics Inc | 250,000 | 1M $ | |
| 24 | BIOFRONTERA INC | 1,163,962 | 941.6K $ | |
| 25 | Kura Oncology Inc | 100,000 | 813K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 25 | 195.7M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Rosalind Advisors, Inc.". https://titelia.com/en/funds/US13F1622627